Skip to main content
Top
Published in: Endocrine 1/2018

01-04-2018 | Original Article

Body composition and sarcopenia in patients with chronic obstructive pulmonary disease

Authors: Tatiana Munhoz da Rocha Lemos Costa, Fabio Marcelo Costa, Thaísa Hoffman Jonasson, Carolina Aguiar Moreira, César Luiz Boguszewski, Victória Zeghbi Cochenski Borba

Published in: Endocrine | Issue 1/2018

Login to get access

Abstract

Purpose

Changes in body composition are commonly present in chronic obstructive pulmonary disease (COPD). The main aim of this study were to evaluate changes in body composition and the prevalence of pre-sarcopenia and sarcopenia in patients with COPD, compared with two control groups and correlate these parameters with indices of COPD severity (VEF1 and GOLD) and prognosis (BODE).

Methods

This was a cross-sectional study in COPD patients (DG) that undergone body composition assessment by DXA. Two control groups were used, smokers individuals without COPD (smokers group, SG), and healthy never smokers individuals (never smokers group, NSG).

Results

DG comprised 121 patients (65 women, mean age 67.9 ± 8.6 years). The percentage of total body fat mass (TFM) was significantly lower in DG in both genders, despite no difference in BMI. Both BMI and relative skeletal muscle mass index (RSMI) decreased according to the worsening of GOLD in men and women, as well as the TFM and total lean mass (TLM) in men. As BODE get worse, BMI and RSMI decreased in both sexes, as well as TLM in men. The prevalence of pre-sarcopenia in the DG was 46.3% and no different with controls. In DG 12.4% were sarcopenic. Patients with sarcopenia were older and had worse prognosis. Higher BODE prognostic index, higher the prevalence of sarcopenia (OR 3.5, 95% CI 1.06–11.56, p = 0.035).

Conclusions

This study showed alterations in body composition parameters in patients with COPD. A high prevalence of sarcopenia and the association with worse prognostic index.
Literature
1.
go back to reference Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease. National Heart, Lung and Blood Institutes. (2011). www.goldcopd.com Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease. National Heart, Lung and Blood Institutes. (2011). www.​goldcopd.​com
2.
go back to reference T.M. Eagan, P. Aukrust, T. Ueland, J.A. Hardie, A. Johannessen, T.E. Mollnes et al. Body composition and plasma levels of inflammatory biomarkers in COPD. Eur. Respir. J. 36(5), 1027–1033 (2010)CrossRefPubMed T.M. Eagan, P. Aukrust, T. Ueland, J.A. Hardie, A. Johannessen, T.E. Mollnes et al. Body composition and plasma levels of inflammatory biomarkers in COPD. Eur. Respir. J. 36(5), 1027–1033 (2010)CrossRefPubMed
3.
4.
go back to reference M. Decramer, W. Janssens, M. Miravitlles, Chronic obstructive pulmonary disease. Lancet 379(9823), 1341–1351 (2012).CrossRefPubMed M. Decramer, W. Janssens, M. Miravitlles, Chronic obstructive pulmonary disease. Lancet 379(9823), 1341–1351 (2012).CrossRefPubMed
5.
go back to reference M.I. Polkey, J. Moxham, Attacking the disease spiral in chronic obstructive pulmonary disease. Clin. Med. 6(2), 190–196 (2006)CrossRef M.I. Polkey, J. Moxham, Attacking the disease spiral in chronic obstructive pulmonary disease. Clin. Med. 6(2), 190–196 (2006)CrossRef
6.
go back to reference P. Tunsupon, M.J. Mador, The influence of body composition on pulmonary rehabilitation outcomes in chronic obstructive pulmonary disease patients. Lung 195(6), 729–738 (2017).CrossRefPubMed P. Tunsupon, M.J. Mador, The influence of body composition on pulmonary rehabilitation outcomes in chronic obstructive pulmonary disease patients. Lung 195(6), 729–738 (2017).CrossRefPubMed
7.
go back to reference A.J. Cruz-Jentoft, F. Landi, S.M. Schneider, C. Zúñiga, H. Arai, Y. Boirie, L.K. Chen, R.A. Fielding, F.C. Martin, J.P. Michel, C. Sieber, J.R. Stout, S.A. Studenski, B. Vellas, J. Woo, M. Zamboni, T. Cederholm, Prevalence of and interventions for sarcopenia in ageing adults: a systematic review. Report of the International Sarcopenia Initiative (EWGSOP and IWGS). Age Ageing 43(6), 748–759 (2014)CrossRefPubMedPubMedCentral A.J. Cruz-Jentoft, F. Landi, S.M. Schneider, C. Zúñiga, H. Arai, Y. Boirie, L.K. Chen, R.A. Fielding, F.C. Martin, J.P. Michel, C. Sieber, J.R. Stout, S.A. Studenski, B. Vellas, J. Woo, M. Zamboni, T. Cederholm, Prevalence of and interventions for sarcopenia in ageing adults: a systematic review. Report of the International Sarcopenia Initiative (EWGSOP and IWGS). Age Ageing 43(6), 748–759 (2014)CrossRefPubMedPubMedCentral
8.
go back to reference M.K. Byun, E.N. Cho, J. Chang, C.M. Ahn, H.J. Kim, Sarcopenia correlates with systemic inflammation in COPD. Int. J. Chron. Obstruct. Pulmon. Dis. 12, 669–675 (2017)CrossRefPubMedPubMedCentral M.K. Byun, E.N. Cho, J. Chang, C.M. Ahn, H.J. Kim, Sarcopenia correlates with systemic inflammation in COPD. Int. J. Chron. Obstruct. Pulmon. Dis. 12, 669–675 (2017)CrossRefPubMedPubMedCentral
9.
go back to reference S.E. Jones, M. Maddocks, S.S. Kon, J.L. Canavan, C.M. Nolan, A.L. Clark, M.I. Polkey, W.D. Man, Sarcopenia in COPD: prevalence, clinical correlates and response to pulmonary rehabilitation. Thorax 70(3), 213–218 (2015)CrossRefPubMed S.E. Jones, M. Maddocks, S.S. Kon, J.L. Canavan, C.M. Nolan, A.L. Clark, M.I. Polkey, W.D. Man, Sarcopenia in COPD: prevalence, clinical correlates and response to pulmonary rehabilitation. Thorax 70(3), 213–218 (2015)CrossRefPubMed
10.
go back to reference C.B. Franco, G. Paz-Filho, P.E. Gomes, V.B. Nascimento, C.A. Kulak, C.L. Boguszewski, V.Z. Borba, Chronic obstructive pulmonary disease is associated with osteoporosis and low levels of vitamin D. Osteoporos. Int. 20(11), 1881–1887 (2009)CrossRefPubMed C.B. Franco, G. Paz-Filho, P.E. Gomes, V.B. Nascimento, C.A. Kulak, C.L. Boguszewski, V.Z. Borba, Chronic obstructive pulmonary disease is associated with osteoporosis and low levels of vitamin D. Osteoporos. Int. 20(11), 1881–1887 (2009)CrossRefPubMed
11.
go back to reference L. Graat-Verboom, E.F. Wouters, F.W. Smeenk, B.E. van den Borne, R. Lunde, M.A. Spruit, Current status of research on osteoporosis in COPD: a systematic review. Eur. Respir. J. 34, 209–218 (2009)CrossRefPubMed L. Graat-Verboom, E.F. Wouters, F.W. Smeenk, B.E. van den Borne, R. Lunde, M.A. Spruit, Current status of research on osteoporosis in COPD: a systematic review. Eur. Respir. J. 34, 209–218 (2009)CrossRefPubMed
12.
go back to reference Y. Yamamoto, M. Yoshikawa, K. Tomoda, Y. Fujita, M. Yamauchi, A. Fukuoka, S. Tamaki, N. Koyama, H. Kimura, Distribution of bone mineral content is associated with body weight and exercise capacity in patients with chronic obstructive pulmonary disease. Respiration 87(2), 158–164 (2014)CrossRefPubMed Y. Yamamoto, M. Yoshikawa, K. Tomoda, Y. Fujita, M. Yamauchi, A. Fukuoka, S. Tamaki, N. Koyama, H. Kimura, Distribution of bone mineral content is associated with body weight and exercise capacity in patients with chronic obstructive pulmonary disease. Respiration 87(2), 158–164 (2014)CrossRefPubMed
13.
go back to reference W. Janssens, A. Lehouck, C. Carremans, R. Bouillon, C. Mathieu, M. Decramer, Vitamin D beyond bones in chronic obstructive pulmonary disease: time to act. Am. J. Respir. Crit. Care Med. 179, 630–636 (2009)CrossRefPubMed W. Janssens, A. Lehouck, C. Carremans, R. Bouillon, C. Mathieu, M. Decramer, Vitamin D beyond bones in chronic obstructive pulmonary disease: time to act. Am. J. Respir. Crit. Care Med. 179, 630–636 (2009)CrossRefPubMed
14.
go back to reference L. Forli, O.J. Mellbye, J. Halse, O. Bjortuft, M. Vatn, J. Boe, Cytokines, bone turnover markers and weight change in candidates for lung transplantation. Pulm. Pharmacol. Ther. 21, 188–195 (2008)CrossRefPubMed L. Forli, O.J. Mellbye, J. Halse, O. Bjortuft, M. Vatn, J. Boe, Cytokines, bone turnover markers and weight change in candidates for lung transplantation. Pulm. Pharmacol. Ther. 21, 188–195 (2008)CrossRefPubMed
15.
go back to reference H.K. Koo, J.H. Park, H.K. Park, H. Jung, S.S. Lee, Conflicting role of sarcopenia and obesity in male patients with chronic obstructive pulmonary disease: Korean National Health and Nutrition Examination Survey. PLoS. One 9(10), e110448 (2014)CrossRefPubMedPubMedCentral H.K. Koo, J.H. Park, H.K. Park, H. Jung, S.S. Lee, Conflicting role of sarcopenia and obesity in male patients with chronic obstructive pulmonary disease: Korean National Health and Nutrition Examination Survey. PLoS. One 9(10), e110448 (2014)CrossRefPubMedPubMedCentral
16.
go back to reference D.A. Lipschitz, Screening for nutritional status in the elderly. Prim. Care 21(1), 55–67 (1994)PubMed D.A. Lipschitz, Screening for nutritional status in the elderly. Prim. Care 21(1), 55–67 (1994)PubMed
17.
go back to reference S.A. Studenski, K.W. Peters, D.E. Alley, P.M. Cawthon, R.R. McLean, T.B. Harris, L. Ferrucci, J.M. Guralnik, M.S. Fragala, A.M. Kenny, D.P. Kiel, S.B. Kritchevsky, M.D. Shardell, T.T. Dam, M.T. Vassileva, The FNIH sarcopenia project: rationale, study description,conference recommendations, and final estimates. J. Gerontol. Ser. A 69(5), 547–558 (2014)CrossRef S.A. Studenski, K.W. Peters, D.E. Alley, P.M. Cawthon, R.R. McLean, T.B. Harris, L. Ferrucci, J.M. Guralnik, M.S. Fragala, A.M. Kenny, D.P. Kiel, S.B. Kritchevsky, M.D. Shardell, T.T. Dam, M.T. Vassileva, The FNIH sarcopenia project: rationale, study description,conference recommendations, and final estimates. J. Gerontol. Ser. A 69(5), 547–558 (2014)CrossRef
18.
go back to reference J. Prignot, Quantification and chemical markers of tobacco-exposure. Eur. J. Respir. Dis. 70(1), 1–7 (1987)PubMed J. Prignot, Quantification and chemical markers of tobacco-exposure. Eur. J. Respir. Dis. 70(1), 1–7 (1987)PubMed
19.
go back to reference B.G. Ferris, Epidemiology standardization project (American Thoracic Society). Am. Rev. Respir. Dis. 118(6 Pt 2), 1–120 (1978)PubMed B.G. Ferris, Epidemiology standardization project (American Thoracic Society). Am. Rev. Respir. Dis. 118(6 Pt 2), 1–120 (1978)PubMed
20.
go back to reference P.W. Jones, G. Harding, P. Berry et al. Development and first validation of the COPD assessment test. Eur. Respir. J. 34(3), 648–654 (2009)CrossRefPubMed P.W. Jones, G. Harding, P. Berry et al. Development and first validation of the COPD assessment test. Eur. Respir. J. 34(3), 648–654 (2009)CrossRefPubMed
21.
go back to reference B. Balke, A simple field test for the assessment of physical fitness. Rep 63–6. Rep Civ Aeromed Res Inst US. 1–8 (1963) B. Balke, A simple field test for the assessment of physical fitness. Rep 63–6. Rep Civ Aeromed Res Inst US. 1–8 (1963)
22.
go back to reference B. Celli, C. Cote, J. Marin et al. The body mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N. Engl. J. Med. 350, 1005–1012 (2004)CrossRefPubMed B. Celli, C. Cote, J. Marin et al. The body mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N. Engl. J. Med. 350, 1005–1012 (2004)CrossRefPubMed
23.
go back to reference D.A. Stern, W.J. Morgan, A.L. Wright, S. Guerra, F.D. Martinez, Poor airway function in early infancy and lung function by age 22 years: a non-selective longitudinal cohort study. Lancet 370(9589), 758–764 (2007)CrossRefPubMedPubMedCentral D.A. Stern, W.J. Morgan, A.L. Wright, S. Guerra, F.D. Martinez, Poor airway function in early infancy and lung function by age 22 years: a non-selective longitudinal cohort study. Lancet 370(9589), 758–764 (2007)CrossRefPubMedPubMedCentral
24.
go back to reference G.M. Hunninghake, M.H. Cho, Y. Tesfaigzi, M.E. Soto-Quiros, L. Avila, J. Lasky-Su, C. Stidley, E. Melén, C. Söderhäll, J. Hallberg, I. Kull, J. Kere, M. Svartengren, G. Pershagen, M. Wickman, C. Lange, D.L. Demeo, C.P. Hersh, B.J. Klanderman, B.A. Raby, D. Sparrow, S.D. Shapiro, E.K. Silverman, A.A. Litonjua, S.T. Weiss, J.C. Celedón, MMP12, lung function, and COPD in high-risk populations. N. Engl. J. Med. 361(27), 2599–2608 (2009)CrossRefPubMedPubMedCentral G.M. Hunninghake, M.H. Cho, Y. Tesfaigzi, M.E. Soto-Quiros, L. Avila, J. Lasky-Su, C. Stidley, E. Melén, C. Söderhäll, J. Hallberg, I. Kull, J. Kere, M. Svartengren, G. Pershagen, M. Wickman, C. Lange, D.L. Demeo, C.P. Hersh, B.J. Klanderman, B.A. Raby, D. Sparrow, S.D. Shapiro, E.K. Silverman, A.A. Litonjua, S.T. Weiss, J.C. Celedón, MMP12, lung function, and COPD in high-risk populations. N. Engl. J. Med. 361(27), 2599–2608 (2009)CrossRefPubMedPubMedCentral
25.
go back to reference A.E. Makarevich, S. Lemiasheuskaya, Dynamics of body composition in male patients during chronic obstructive pulmonary disease (COPD) development. Pneumonol. Alergol. Pol. 83(6), 424–430 (2015)CrossRefPubMed A.E. Makarevich, S. Lemiasheuskaya, Dynamics of body composition in male patients during chronic obstructive pulmonary disease (COPD) development. Pneumonol. Alergol. Pol. 83(6), 424–430 (2015)CrossRefPubMed
26.
go back to reference S.B. Kim, Y.A. Kang, J.Y. Jung, M.S. Park, Y.S. Kim, S.K. Kim, J. Chang, E.Y. Kim, Body mass index and fat free mass index in obstructive lung disease in Korea. Int. J. Tuberc. Lung Dis. 18(1), 102–108 (2014)CrossRefPubMed S.B. Kim, Y.A. Kang, J.Y. Jung, M.S. Park, Y.S. Kim, S.K. Kim, J. Chang, E.Y. Kim, Body mass index and fat free mass index in obstructive lung disease in Korea. Int. J. Tuberc. Lung Dis. 18(1), 102–108 (2014)CrossRefPubMed
27.
go back to reference M. Lainscak, S. von Haehling, W. Doehner, I. Sarc, T. Jeric, K. Ziherl, M. Kosnik, S.D. Anker, S. Suskovic, Body mass index and prognosis in patients hospitalized with acute exacerbation of chronic obstructive pulmonary disease. J. Cachex-. Sarcopenia Muscle 2(2), 81–86 (2011)CrossRef M. Lainscak, S. von Haehling, W. Doehner, I. Sarc, T. Jeric, K. Ziherl, M. Kosnik, S.D. Anker, S. Suskovic, Body mass index and prognosis in patients hospitalized with acute exacerbation of chronic obstructive pulmonary disease. J. Cachex-. Sarcopenia Muscle 2(2), 81–86 (2011)CrossRef
28.
go back to reference N.S. Hopkinson, R.C. Tennant, M.J. Dayer, E.B. Swallow, T.T. Hansel, J. Moxham, M.I. Polkey, A prospective study of decline in fat free mass and skeletal muscle strength in chronic obstructive pulmonary disease. Respir. Res. 8, 25 (2007)CrossRefPubMedPubMedCentral N.S. Hopkinson, R.C. Tennant, M.J. Dayer, E.B. Swallow, T.T. Hansel, J. Moxham, M.I. Polkey, A prospective study of decline in fat free mass and skeletal muscle strength in chronic obstructive pulmonary disease. Respir. Res. 8, 25 (2007)CrossRefPubMedPubMedCentral
29.
go back to reference B. Van den Borst, H.R. Gosker, A.M. Schols, Central fat and peripheral muscle: partners in crime in chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 187(1), 8–13 (2013)CrossRefPubMed B. Van den Borst, H.R. Gosker, A.M. Schols, Central fat and peripheral muscle: partners in crime in chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 187(1), 8–13 (2013)CrossRefPubMed
30.
go back to reference A.M. Abbatecola, A. Fumagalli, L. Spazzafumo, V. Betti, C. Misuraca, A. Corsonello, A. Cherubini, E.E. Guffanti, F. Lattanzio, Body composition markers in older persons with COPD. Age Ageing 43(4), 548–553 (2014)CrossRefPubMed A.M. Abbatecola, A. Fumagalli, L. Spazzafumo, V. Betti, C. Misuraca, A. Corsonello, A. Cherubini, E.E. Guffanti, F. Lattanzio, Body composition markers in older persons with COPD. Age Ageing 43(4), 548–553 (2014)CrossRefPubMed
31.
go back to reference V. Andrianopoulos, E.F. Wouters, V.M. Pinto-Plata, L.E. Vanfleteren, P.S. Bakke, F.M. Franssen, A. Agusti, W. MacNee, S.I. Rennard, R. Tal-Singer, I. Vogiatzis, J. Vestbo, B.R. Celli, M.A. Spruit, Prognostic value of variables derived from the six-minute walk test in patients with COPD: Results from the ECLIPSE study. Respir. Med. 109(9), 1138–1146 (2015)CrossRefPubMed V. Andrianopoulos, E.F. Wouters, V.M. Pinto-Plata, L.E. Vanfleteren, P.S. Bakke, F.M. Franssen, A. Agusti, W. MacNee, S.I. Rennard, R. Tal-Singer, I. Vogiatzis, J. Vestbo, B.R. Celli, M.A. Spruit, Prognostic value of variables derived from the six-minute walk test in patients with COPD: Results from the ECLIPSE study. Respir. Med. 109(9), 1138–1146 (2015)CrossRefPubMed
32.
go back to reference R.T. Jagoe, M.P. Engelen, Muscle wasting and changes in muscle protein metabolism in chronic obstructive pulmonary disease. Eur. Respir. J. 46, 52s–63s (2003)CrossRef R.T. Jagoe, M.P. Engelen, Muscle wasting and changes in muscle protein metabolism in chronic obstructive pulmonary disease. Eur. Respir. J. 46, 52s–63s (2003)CrossRef
33.
go back to reference T.T. Dam, K.W. Peters, M. Fragala, P.M. Cawthon, T.B. Harris, R. McLean, M. Shardell, D.E. Alley, A. Kenny, L. Ferrucci, J. Guralnik, D.P. Kiel, S. Kritchevsky, M.T. Vassileva, S. Studenski, An evidence-based comparison of operational criteria for the presence of sarcopenia. J. Gerontol. Ser. A 69(5), 584–590 (2014)CrossRef T.T. Dam, K.W. Peters, M. Fragala, P.M. Cawthon, T.B. Harris, R. McLean, M. Shardell, D.E. Alley, A. Kenny, L. Ferrucci, J. Guralnik, D.P. Kiel, S. Kritchevsky, M.T. Vassileva, S. Studenski, An evidence-based comparison of operational criteria for the presence of sarcopenia. J. Gerontol. Ser. A 69(5), 584–590 (2014)CrossRef
34.
go back to reference F.M. Franssen, H.P. Sauerwein, E.P. Rutten, E.F. Wouters, A.M. Schols, Whole-body resting and exercise-induced lipolysis in sarcopenic [corrected] patients with COPD. Eur. Respir. J. 32(6), 1466–1471 (2008)CrossRefPubMed F.M. Franssen, H.P. Sauerwein, E.P. Rutten, E.F. Wouters, A.M. Schols, Whole-body resting and exercise-induced lipolysis in sarcopenic [corrected] patients with COPD. Eur. Respir. J. 32(6), 1466–1471 (2008)CrossRefPubMed
35.
go back to reference F. Maltais, Body composition in COPD: looking beyond BMI. Int. J. Tuberc. Lung. Dis. 18(1), 3–4 (2014)CrossRefPubMed F. Maltais, Body composition in COPD: looking beyond BMI. Int. J. Tuberc. Lung. Dis. 18(1), 3–4 (2014)CrossRefPubMed
36.
go back to reference L.W. Lee, C.M. Lin, H.C. Li, P.L. Hsiao, A.C. Chung, C.J. Hsieh, P.C. Wu, S.F. Hsu, Body composition changes in male patients with chronic obstructive pulmonary disease: aging or disease process? PLoS. One 12(7), e0180928 (2017)CrossRefPubMedPubMedCentral L.W. Lee, C.M. Lin, H.C. Li, P.L. Hsiao, A.C. Chung, C.J. Hsieh, P.C. Wu, S.F. Hsu, Body composition changes in male patients with chronic obstructive pulmonary disease: aging or disease process? PLoS. One 12(7), e0180928 (2017)CrossRefPubMedPubMedCentral
37.
go back to reference A.M. Schols, R. Broekhuizen, C.A. Weling-Scheepers, E.F. Wouters, Body composition and mortality in chronic obstructive pulmonary disease. Am. J. Clin. Nutr. 82(1), 53–59 (2005)CrossRefPubMed A.M. Schols, R. Broekhuizen, C.A. Weling-Scheepers, E.F. Wouters, Body composition and mortality in chronic obstructive pulmonary disease. Am. J. Clin. Nutr. 82(1), 53–59 (2005)CrossRefPubMed
38.
go back to reference J.R. Guthrie, P.R. Ebeling, J.L. Hopper, E. Barrett-Connor, L. Dennerstein, E.C. Dudley, H.G. Burger, J.D. Wark, A prospective study of bone loss in menopausal Australian-born women. Osteoporos. Int. 8(3), 282–290 (1998)CrossRefPubMed J.R. Guthrie, P.R. Ebeling, J.L. Hopper, E. Barrett-Connor, L. Dennerstein, E.C. Dudley, H.G. Burger, J.D. Wark, A prospective study of bone loss in menopausal Australian-born women. Osteoporos. Int. 8(3), 282–290 (1998)CrossRefPubMed
39.
go back to reference K. Zhu, M. Hunter, A. James, E.M. Lim, J.P. Walsh, Associations between body mass index, lean and fat body mass and bone mineral density in middle-aged Australians: The Busselton Healthy Ageing Study. Bone 74, 146–152 (2015)CrossRefPubMed K. Zhu, M. Hunter, A. James, E.M. Lim, J.P. Walsh, Associations between body mass index, lean and fat body mass and bone mineral density in middle-aged Australians: The Busselton Healthy Ageing Study. Bone 74, 146–152 (2015)CrossRefPubMed
40.
go back to reference S.F. Vondracek, N.F. Voelkel, M.T. McDermott, C. Valdez, The relationship between adipokines, body composition, and bone density in men with chronic obstructive pulmonary disease. Int. J. Chron. Obstruct. Pulmon. Dis. 4, 267–277 (2009)CrossRefPubMedPubMedCentral S.F. Vondracek, N.F. Voelkel, M.T. McDermott, C. Valdez, The relationship between adipokines, body composition, and bone density in men with chronic obstructive pulmonary disease. Int. J. Chron. Obstruct. Pulmon. Dis. 4, 267–277 (2009)CrossRefPubMedPubMedCentral
Metadata
Title
Body composition and sarcopenia in patients with chronic obstructive pulmonary disease
Authors
Tatiana Munhoz da Rocha Lemos Costa
Fabio Marcelo Costa
Thaísa Hoffman Jonasson
Carolina Aguiar Moreira
César Luiz Boguszewski
Victória Zeghbi Cochenski Borba
Publication date
01-04-2018
Publisher
Springer US
Published in
Endocrine / Issue 1/2018
Print ISSN: 1355-008X
Electronic ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-018-1533-4

Other articles of this Issue 1/2018

Endocrine 1/2018 Go to the issue